Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25

Reuters

2025/08/06

Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25

Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2557312560"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2557312560\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2557312560?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-06 05:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557312560","market":"fut","top_or_hot":-1,"title":"Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArdent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-08-06 05:09</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARDT","symbol_name":"Ardent Health Partners (2024 New Filing)","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL1XF8FH:1","article_id":"2557312560","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557312560","pubTimestamp":1754428164,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ARDT":"Ardent Health Partners (2024 New Filing)"},"translate_title":"Ardent Health Inc.报告2025年第二季度总收入增长11.9%，调整后EBITDA增长38.9%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARDT":0.9},"content_text":"Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n    \n\n        Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}